For example, if 5- HT2A activation is theorized to be causing the therapeutic effects, researchers should have evidence of baseline 5-HT2A problems (however defined) and post-test evidence of sustained 5-HT2A change corresponding to reduced depression scores. The gene discussed is HTR2A; the disease is major depressive disorder.